Genome-wide association and polygenic risk score analysis of prediabetes in South Indian women
This study of South Indian women identified a suggestive regional signal at the MTNR1B locus associated with prediabetes and demonstrated that while a European-derived polygenic risk score shows a significant association with the condition, its predictive accuracy remains weak, underscoring the need for ancestry-specific models.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Long before a person receives a diagnosis of type 2 diabetes, their body often begins to struggle with managing sugar. This intermediate stage, known as prediabetes, is a critical warning sign where blood glucose levels are higher than normal but not yet high enough to be classified as full-blown diabetes. It is a window of opportunity; during this time, the damage is often reversible through lifestyle changes, preventing the progression to a chronic disease that can lead to heart problems and other serious complications. While scientists have mapped out many of the genetic factors that lead to type 2 diabetes, the specific genetic triggers that cause this earlier, pre-diabetic stage remain much less understood. This is particularly true for South Asian populations, who develop diabetes at younger ages and lower body weights than people of other ancestries, yet have been largely missing from large-scale genetic studies. Understanding the genetic roots of prediabetes in these groups is essential for creating better tools to identify who is at risk and when to intervene.
A team of researchers from the Central University of Kerala set out to fill this gap by looking directly at the DNA of women in northern Kerala, India. They focused specifically on women who had prediabetes and compared them to women with normal blood sugar levels, deliberately leaving out those who already had diabetes. This approach allowed them to see the genetic signals associated with the earliest signs of trouble, before the body had been altered by years of high blood sugar or the medications used to treat it. The study involved 540 women, aged 30 to 60, who were recruited from the Kasaragod district. After rigorous checks to ensure the quality of their genetic data, the researchers analyzed the DNA of 471 participants, examining hundreds of thousands of tiny variations in their genetic code to see if any were more common in the women with prediabetes.
The search revealed a clear pattern centered on a specific gene called MTNR1B. This gene is involved in how the body handles melatonin, a hormone that regulates sleep, and it has long been known to play a role in blood sugar control. The researchers found that a specific variation in this gene was more common in the women with prediabetes, representing a suggestive association that aligns with previous research in other South Asian groups. In fact, women carrying this genetic variant had approximately 1.83 times the odds of having prediabetes compared to those without it. This finding reinforces the idea that this gene is a key player in the early stages of blood sugar dysregulation. The team also looked at the surrounding DNA to see if the signal was coming from a single point or a cluster of related variations. They found that the risk was carried by a specific combination of genetic markers, or a haplotype, that spans a small region of the chromosome, suggesting that the entire local genetic structure contributes to the risk rather than just one isolated letter in the genetic code.
Beyond looking at single genes, the researchers tested whether a "polygenic risk score" could predict who had prediabetes. A polygenic risk score is a tool that adds up the effects of many different genetic variants across the entire genome to estimate a person's overall inherited risk for a disease. The team used a score that had been developed for type 2 diabetes and applied it to their group of women with prediabetes. The results showed that the score did work to some extent: women with higher scores were indeed more likely to have prediabetes. However, the tool was not very precise. While it could distinguish between the two groups better than random chance, it was far from perfect, correctly identifying the status of a woman only slightly more often than a coin toss would. This suggests that while the genetic blueprint for diabetes is present in the prediabetic stage, the current tools built for full-blown diabetes are not yet sensitive enough to pinpoint the condition with high accuracy in this specific population.
The study concludes that while we have identified a strong genetic link to early blood sugar problems in South Indian women, specifically involving the melatonin receptor gene, our ability to use this information for prediction is still limited. The genetic signal found at the MTNR1B locus is a genuine and important discovery that helps explain why some people develop dysglycemia early in life. However, the broader genetic risk scores, which work well for established diabetes, do not yet translate effectively to the prediabetic stage in this group. This highlights a need for new, more tailored genetic models that are built specifically for South Asian populations and for the specific stage of prediabetes. Until such tools are developed, the most reliable way to manage this risk remains the proven method of lifestyle modification, but these genetic findings provide a clearer picture of the biological roots of the problem, offering hope for more precise prevention strategies in the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.